drugset / Trial / NCT05452928
Aciclovir Versus Placebo for HSV-2 Meningitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine whether active treatment with (val)acyclovir is superior for treatment of viral meningitis compared with placebo assessed by numbers meeting a primary, objective endpoint at 7 days after randomisation
Timeline
- Start
- 2026-06-01
- Primary completion
- 2028-06-01
- Completion
- 2029-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acyclovir | Small molecule | 10 mg/kg | — |
| Comparator | Valacyclovir | Unknown | 1 g | Oral |